We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Breakthrough Report for Microbiology Lab Results a Game-Changer for Infectious Disease Treatment

By LabMedica International staff writers
Posted on 28 Aug 2023
Print article
Image: The OneChoice report for microbiology lab results empowers clinicians to provide optimal care (Photo courtesy of Arkstone)
Image: The OneChoice report for microbiology lab results empowers clinicians to provide optimal care (Photo courtesy of Arkstone)

Infectious pathogens continually evolve, becoming stronger and more strategic as they adapt to new environments and develop resistance to existing treatments. Despite this ongoing evolution, the essential technologies in the fight against antimicrobial resistance (AMR) often lag behind. While pathogens advance, clinical tools can become outdated, failing to provide physicians with accurate and timely information. For example, obsolete lab reporting technologies not only lack efficiency but also hamper the battle against AMR. Now, a cutting-edge decision-supporting clinical tool is bridging this gap by utilizing modern technologies for precise, rapid, and effective patient care in the digital age.

Arkstone Medical Solutions (Boca Raton, FL, USA) has introduced a groundbreaking advancement—the OneChoice report for microbiology lab results. Building on the success of its molecular lab results OneChoice report, which has benefited countless patients and earned the trust of numerous healthcare providers, Arkstone has extended its revolutionary technology to the realm of microbiology. The OneChoice report represents a transformative step in infectious disease treatment. Unlike traditional microbiology lab reports that present raw text data for interpretation, Arkstone's OneChoice decision engine analyzes a range of factors to provide precision-guided treatment recommendations. By harnessing advanced artificial intelligence and a deep understanding of infectious diseases, Arkstone empowers healthcare providers with personalized medicine tailored to each patient's specific requirements.

At the heart of the OneChoice report is the PathFinder system, which identifies potentially pathogenic organisms within samples, laying the foundation for more accurate treatment decisions. This innovative tool considers various sensitivities tested in the lab and evaluates their relevance based on the source of the sample. Additionally, the report features the MedsMatrix, a visual table that highlights effective drugs alongside considerations like allergies or pregnancy status. The report also offers OneChoice Plus—an interactive online version accessed through a QR code on each report. OneChoice Plus equips clinicians with a comprehensive toolkit for efficient patient care management. It provides tools for dosage adjustments, drug references, drug interaction checks, GFR, and CrCL calculators—all at the fingertips of physicians. Furthermore, OneChoice Plus offers translations in multiple languages, facilitating clear communication and comprehension for healthcare providers and patients across the world.

"We are thrilled to introduce these groundbreaking advancements to our OneChoice report," says Dr. Ari Frenkel, infectious disease specialist, and Co-Founder & Chief Science Officer of Arkstone. "Precision-guided medicine is the future of infectious disease treatment, and our latest innovations will empower clinicians to provide optimal care while upholding antimicrobial stewardship principles."

"With the launch of the OneChoice report for microbiology lab results, Arkstone is poised to make an even greater impact on the healthcare landscape," said Dave Gross, Co-Founder & CTO of Arkstone. "Our commitment to evidence-based information and continuous innovation has positioned us as the trusted partner for healthcare providers worldwide. By expanding our technology to microbiology, we're enabling healthcare providers to make more informed decisions and ultimately improve patient outcomes."

Related Links:
Arkstone Medical Solutions 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.